A practical provider's guide to helping patients locate and access Ebglyss (Lebrikizumab) in 2026, with 5 actionable workflow steps.
As a prescriber treating moderate-to-severe atopic dermatitis, you've likely encountered the frustration firsthand: you prescribe Ebglyss (Lebrikizumab-lbkz), and your patient calls back days later saying they can't find it. The pharmacy doesn't have it. Their insurance wants a prior authorization. They're confused, frustrated, and their eczema is flaring.
This guide gives you a practical, step-by-step workflow to help your patients access Ebglyss as smoothly as possible in 2026.
Ebglyss, Eli Lilly's IL-13 inhibitor biologic, was approved by the FDA in September 2024. It's not in a formal shortage — the FDA and ASHP databases show no active supply disruption. However, real-world access remains challenging for several reasons:
From the patient's perspective, the experience often looks like this:
The root cause is almost always a distribution channel mismatch — the prescription needs to go through a specialty pharmacy, not a retail one. By proactively routing the prescription correctly and setting expectations, you can prevent this cycle entirely.
The single most impactful thing you can do is skip the retail pharmacy entirely. Send the Ebglyss prescription directly to a specialty pharmacy that carries it. Major networks currently dispensing Ebglyss include:
Confirm which specialty pharmacy is preferred by the patient's insurance plan before sending the prescription. This one step can save days of delays.
Don't wait for the pharmacy to trigger the prior authorization process — initiate it from your office at the time of prescribing. Have your PA team prepare documentation that includes:
A well-documented PA submission significantly increases the likelihood of first-pass approval.
Cost surprises are one of the top reasons patients abandon specialty prescriptions. During the office visit, enroll eligible patients in:
Having financial assistance in place before the first prescription ships prevents sticker shock and treatment discontinuation.
Medfinder for Providers allows your practice staff to quickly check which specialty pharmacies in your area have Ebglyss in stock. Instead of your staff spending 30 minutes calling pharmacies, they can verify availability in seconds.
Integrate Medfinder into your prescribing workflow so that you're confirming stock before the prescription goes out — not after the patient has already waited days.
Many access problems stem from patients not understanding the specialty pharmacy process. During the visit, clearly explain:
Setting these expectations upfront dramatically reduces patient anxiety and inbound calls to your practice.
When Ebglyss isn't accessible or insurance won't cover it, have a backup plan ready:
Having pre-identified backup options allows you to pivot quickly when the first-choice medication encounters access barriers.
Maintain a current list of specialty pharmacies that stock Ebglyss, including contact numbers, fax lines, and the insurance plans they accept. Share this list with your PA coordinators and nursing staff.
Develop a standardized prior authorization letter template for Ebglyss that includes all commonly requested clinical information. This saves time on each submission and ensures consistency.
Implement a tracking system (even a simple spreadsheet) for specialty prescriptions. Log the date the PA was submitted, approval status, expected fill date, and patient communication. This prevents prescriptions from falling through the cracks.
If your practice prescribes biologics regularly, consider designating a staff member as your biologics coordinator. This person becomes the expert on specialty pharmacy workflows, PA requirements, and manufacturer programs — making the process smoother for everyone.
The access challenges with Ebglyss in 2026 are real but manageable. By routing prescriptions directly to specialty pharmacies, initiating PAs proactively, enrolling patients in financial assistance early, and using tools like Medfinder for Providers, you can significantly reduce the friction your patients experience.
Your patients trust you to guide them through the treatment process — not just the clinical decision, but the logistics of actually getting the medication in hand. A few process improvements in your practice workflow can make all the difference.
For the latest on Ebglyss availability and prescribing considerations, visit medfinder.com/providers. For patient-facing resources, direct patients to our guides on finding Ebglyss in stock and saving money on Ebglyss.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.
%2C%20Color%3DOriginal.png)
